Related Experiment Video
Updated: Nov 26, 2025

Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
Published on: August 12, 2019
Clinical neuro-oncology for the neurologist
Rimas V Lukas1, Jennie W Taylor1, Sylvia C Kurz1
1Department of Neurology (RVL), Northwestern University, Chicago, IL; The Lou & Jean Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center (RVL), Chicago, IL; Departments of Neurology and Neurological Surgery (JWT), University of California-San Francisco; Department of Neurology (SCK), New York University, New York; Brain and Spine Tumor Center at the Perlmutter Cancer Center (SCK), New York, NY; and Department of Neurology (NAM), University of Rochester, NY.
Purpose Of Review:
Neuro-oncologic patients are routinely encountered in clinical practice. Neuro-oncology is a rapidly evolving field, so understanding the most classic paradigms and contemporary advances will optimize patient care.
Recent Findings:
We discuss the recent reclassification of tumors via molecular characteristics as it applies to direct clinical practice and review the contemporary standard of care for infiltrating gliomas, meningiomas, brain metastases, and CNS lymphoma.
Summary:
We provide a straightforward primer on neuro-oncology with a focus on the brain tumors most commonly encountered by the adult neurologist and a clear emphasis on clinically relevant points including those which have recently become incorporated into our standard management. We cite key reviews to allow interested readers an opportunity to gain a more comprehensive understanding of specific topics.
Related Concept Videos
Treatment Resistant Cancers
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Neurogenesis and Regeneration of Nervous Tissue
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

